Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

43.18
Delayed Data
As of Mar 23
 +0.64 / +1.50%
Today’s Change
41.57
Today|||52-Week Range
85.83
-13.33%
Year-to-Date
Asia bourses slip after release of China data
Mar 07 / FT.com - Paid Partner Content
Trump's pledge on drug pricing squeezes pharma stocks
Mar 07 / FT.com - Paid Partner Content

Today’s Trading

Previous close42.54
Today’s open42.58
Day’s range42.54 - 43.99
Volume2,486,668
Average volume (3 months)2,393,914
Market cap$4.5B
Dividend yield--
Data as of 03/23/2017

Growth & Valuation

Earnings growth (last year)+78.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+1.01%
P/E ratio23.6
Price/Sales2.30
Price/Book0.88

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-0.08-0.14%
GRFSGrifols SA+0.21+1.18%
IONSIonis Pharmaceutical...-0.21-0.55%
OPKOPKO Health Inc-0.21-2.67%
Data as of 03/23/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$1.63
Annual revenue (last year)$3.4B
Annual profit (last year)$548.0M
Net profit margin14.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts


Search for Jobs